AM Couroucé

811 total citations
30 papers, 589 citations indexed

About

AM Couroucé is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, AM Couroucé has authored 30 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 16 papers in Hepatology and 8 papers in Immunology. Recurrent topics in AM Couroucé's work include Hepatitis B Virus Studies (16 papers), Hepatitis C virus research (15 papers) and Liver Disease Diagnosis and Treatment (6 papers). AM Couroucé is often cited by papers focused on Hepatitis B Virus Studies (16 papers), Hepatitis C virus research (15 papers) and Liver Disease Diagnosis and Treatment (6 papers). AM Couroucé collaborates with scholars based in France, Sweden and Taiwan. AM Couroucé's co-authors include Isa K. Mushahwar, Shin‐Da Lee, Heléne Norder, Berit Hammas, L. O. Magnius, K.M. Bile, Josiane Pillonel, C. Saura, Françoise Bouchardeau and J.‐J. Lefrère and has published in prestigious journals such as The Lancet, The Journal of Infectious Diseases and Journal of General Virology.

In The Last Decade

AM Couroucé

29 papers receiving 567 citations

Peers

AM Couroucé
Paul P. Ulrich United States
Sigrid Nick Germany
Paul F. Coleman United States
Natàlia Casamitjana Spain
Megan E. Laycock United States
Jungsuh P. Kim United States
A.M. Couroucé France
P Maupas France
Daniel P. Kolk United States
Bruce J. Dille United States
Paul P. Ulrich United States
AM Couroucé
Citations per year, relative to AM Couroucé AM Couroucé (= 1×) peers Paul P. Ulrich

Countries citing papers authored by AM Couroucé

Since Specialization
Citations

This map shows the geographic impact of AM Couroucé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AM Couroucé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AM Couroucé more than expected).

Fields of papers citing papers by AM Couroucé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by AM Couroucé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AM Couroucé. The network helps show where AM Couroucé may publish in the future.

Co-authorship network of co-authors of AM Couroucé

This figure shows the co-authorship network connecting the top 25 collaborators of AM Couroucé. A scholar is included among the top collaborators of AM Couroucé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with AM Couroucé. AM Couroucé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bouchardeau, Françoise, Syria Laperche, Josiane Pillonel, et al.. (2000). GB Virus type C/HGV markers in HCV RNA‐positive French blood donors: correlation with HCV genotypes and risk factors. Transfusion. 40(7). 875–878. 2 indexed citations
2.
Lemaire, J.M., AM Couroucé, Christine Defer, et al.. (2000). HCV RNA in blood donors with isolated reactivities by third‐generation RIBA. Transfusion. 40(7). 867–870. 14 indexed citations
3.
Couroucé, AM, Josiane Pillonel, & C. Saura. (2000). Dépistage des marqueurs des infections transmissibles par transfusion sur les dons collectés en France de 1996 à 1998. Transfusion Clinique et Biologique. 7(2). 153–170. 12 indexed citations
4.
Elghouzzi, M.H., Françoise Bouchardeau, Josiane Pillonel, et al.. (2000). Hepatitis C Virus: Routes of Infection and Genotypes in a Cohort of Anti‐HCV‐Positive French Blood Donors. Vox Sanguinis. 79(3). 138–144. 31 indexed citations
5.
Laperche, Syria, A Girault, Anne Kolko, et al.. (1999). Prevalence of present and past hepatitis G virus infection in a French haemodialysis centre. Nephrology Dialysis Transplantation. 14(11). 2692–2697. 11 indexed citations
6.
Pillonel, Josiane, C. Saura, & AM Couroucé. (1998). Prévalence du VIH, de l'HTLV et des virus des hépatites B et C chez les donneurs de sang en France, 1992–1996. Transfusion Clinique et Biologique. 5(5). 305–312. 32 indexed citations
7.
Bouchardeau, Françoise, Josiane Pillonel, Patrick Maisonneuve, et al.. (1998). O9-3 L'infection par le virus de l'hépatite C (VHC) dans une population de donneurs de sang: génotypes et facteurs de risque. Transfusion Clinique et Biologique. 5. 114s–114s. 1 indexed citations
8.
Bouchardeau, Françoise, Philippe Chauveau, AM Couroucé, & J.-L. Poignet. (1995). Genotype distribution and transmission of hepatitis C virus (HCV) in French haemodialysed patients. Nephrology Dialysis Transplantation. 10(12). 2250–2252. 10 indexed citations
9.
Couroucé, AM. (1995). Réévaluation de la sensibilité des trousses de dépistage des anticorps anti-HIV. Transfusion Clinique et Biologique. 2(5). 395–408. 9 indexed citations
10.
Norder, Heléne, Berit Hammas, Shin‐Da Lee, et al.. (1993). Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen. Journal of General Virology. 74(7). 1341–1348. 302 indexed citations
11.
Wattel, Eric, Martine Mariotti, Emmanuel Gordien, et al.. (1992). Human T Lymphotropic Virus (HTLV) Type I and II DNA Amplification in HTLV-I/II-Seropositive Blood Donors of the French West Indies. The Journal of Infectious Diseases. 165(2). 369–372. 19 indexed citations
12.
Vittecoq, Daniel, Françoise Barré‐Sinoussi, AM Couroucé, et al.. (1992). Passive Immunotherapy in AIDS: A Randomized Trial of Serial Human Immunodeficiency Virus-Positive Transfusions of Plasma Rich in p24 Antibodies versus Transfusions of Seronegative Plasma. The Journal of Infectious Diseases. 165(2). 364–368. 55 indexed citations
13.
Lefrère, J.‐J., Daniel Vittecoq, G Boulard, et al.. (1991). Immunothérapie passive dans le SIDA : utilisation transfusionnelle de plasma riche en anticorps anti-p25 (essai de phase I). PubMed. 34(3). 199–211. 1 indexed citations
14.
Couroucé, AM. (1991). Prévention d'une infection par le virus de l'hépatite B. Immuno-analyse & Biologie Spécialisée. 6(2). 41–45. 1 indexed citations
15.
Neurath, A. R., Stephen B. H. Kent, N. Strick, et al.. (1987). Antibodies to synthetic peptides from the pre-S1 and pre-S2 regions of one subtype of the hepatitis B virus (HBV) envelope protein recognize all HBV subtypes. Molecular Immunology. 24(9). 975–980. 33 indexed citations
16.
Thiers, Valérie, Françoise Bouchardeau, AM Couroucé, Pierre Tiollais, & C. Bréchot. (1986). [Hepatitis B virus DNA as a marker of viral multiplication: comparison with HBe antigen and anti-HBe antibody].. PubMed. 15(26). 1219–22. 8 indexed citations
17.
Couroucé, AM, et al.. (1984). Détection d'anticorps spécifiques du HTLV chez les donneurs de sang Français. Revue Franç aise de Transfusion et Immuno-hé matologie. 27(4). 509–511.
18.
Habibi, B., Jean‐Pierre Allain, & AM Couroucé. (1983). Transfusion sanguine et syndrome d'immunodépression acquise (SIDA). Revue Franç aise de Transfusion et Immuno-hé matologie. 26(5). 447–465. 3 indexed citations
19.
Bouchardeau, Françoise, et al.. (1982). Utilisation du vaccin contre le virus B de l'hépatite chez les donneurs bénévoles déjà immunisés contre ce virus. Revue Franç aise de Transfusion et Immuno-hé matologie. 25(5). 473–485. 1 indexed citations
20.
Soulier, Jean & AM Couroucé. (1981). Progrès concernant les hépatites virales. Revue Franç aise de Transfusion et Immuno-hé matologie. 24(5). 501–517. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul P. Ulrich Breakdown of academic impact, for papers by Sigrid Nick Breakdown of academic impact, for papers by Paul F. Coleman Breakdown of academic impact, for papers by Natàlia Casamitjana Breakdown of academic impact, for papers by Megan E. Laycock Breakdown of academic impact, for papers by Jungsuh P. Kim Breakdown of academic impact, for papers by A.M. Couroucé Breakdown of academic impact, for papers by P Maupas Breakdown of academic impact, for papers by Daniel P. Kolk Breakdown of academic impact, for papers by Bruce J. Dille
Rankless by CCL
2026